Related Experiment Video
Updated: Sep 5, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.6K
Deep brain stimulation for Parkinson's disease
Marwan Hariz1,2, Patric Blomstedt1
1Department of Clinical Neuroscience, University Hospital of Umeå, Umeå, Sweden.
Journal of Internal Medicine
|July 7, 2022
Summary
Deep brain stimulation (DBS) offers symptomatic relief for advanced Parkinson's disease (PD) when medications fail. The subthalamic nucleus (STN) is a preferred DBS target, though patient selection and multidisciplinary care are crucial for optimal outcomes.
Area of Science:
- Neurosurgery
- Neurology
- Movement Disorders
Background:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder with motor and non-motor symptoms.
- Deep brain stimulation (DBS) is a neurosurgical option for advanced PD when medical management is insufficient or causes severe side effects.
- DBS targets specific brain regions within the basal ganglia-thalamus circuitry to alleviate PD symptoms.
Purpose of the Study:
- To review the efficacy and considerations of Deep Brain Stimulation (DBS) for Parkinson's disease (PD).
- To highlight the subthalamic nucleus (STN) as a preferred target for DBS in PD.
- To emphasize patient selection criteria and the necessity of multidisciplinary teams for DBS in PD.
Main Methods:
- Review of existing literature on Deep Brain Stimulation (DBS) for Parkinson's disease (PD).
- Analysis of different DBS targets (thalamus, pallidum, STN) and their symptom-specific efficacies.
- Discussion of patient eligibility, contraindications, side effects, and long-term outcomes of DBS for PD.
Main Results:
- DBS effectively manages motor symptoms like tremors, rigidity, and dyskinesias in advanced PD.
- The subthalamic nucleus (STN) is often the preferred target due to its broad efficacy and potential for medication reduction.
- Dysarthria is a common side effect, and DBS efficacy may wane for non-dopaminergic axial symptoms over time.
Conclusions:
- DBS is a valuable therapeutic option for select Parkinson's disease patients with advanced symptoms.
- Careful patient selection, considering age, cognitive status, and axial symptoms, is essential for successful STN DBS.
- Specialized multidisciplinary teams are required for optimal patient management and follow-up in DBS therapy for PD.

